Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP202159.RADRX5DtwCX8_E4ughvs45avd5zwLB4P_3s_QeHIwWfOE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP202159.RADRX5DtwCX8_E4ughvs45avd5zwLB4P_3s_QeHIwWfOE130_assertion type Assertion NP202159.RADRX5DtwCX8_E4ughvs45avd5zwLB4P_3s_QeHIwWfOE130_head.
- NP202159.RADRX5DtwCX8_E4ughvs45avd5zwLB4P_3s_QeHIwWfOE130_assertion description "[Data suggest that AMACR is essential for optimal growth of prostate cancer cells in vitro and that this enzyme has the potential to be a complementary target with androgen ablation in PCa treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP202159.RADRX5DtwCX8_E4ughvs45avd5zwLB4P_3s_QeHIwWfOE130_provenance.
- NP202159.RADRX5DtwCX8_E4ughvs45avd5zwLB4P_3s_QeHIwWfOE130_assertion evidence source_evidence_literature NP202159.RADRX5DtwCX8_E4ughvs45avd5zwLB4P_3s_QeHIwWfOE130_provenance.
- NP202159.RADRX5DtwCX8_E4ughvs45avd5zwLB4P_3s_QeHIwWfOE130_assertion SIO_000772 14612535 NP202159.RADRX5DtwCX8_E4ughvs45avd5zwLB4P_3s_QeHIwWfOE130_provenance.
- NP202159.RADRX5DtwCX8_E4ughvs45avd5zwLB4P_3s_QeHIwWfOE130_assertion wasDerivedFrom lhgdn-20090331 NP202159.RADRX5DtwCX8_E4ughvs45avd5zwLB4P_3s_QeHIwWfOE130_provenance.
- NP202159.RADRX5DtwCX8_E4ughvs45avd5zwLB4P_3s_QeHIwWfOE130_assertion wasGeneratedBy ECO_0000203 NP202159.RADRX5DtwCX8_E4ughvs45avd5zwLB4P_3s_QeHIwWfOE130_provenance.